Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

World News: . []

CAMBRIDGE Mass Nov 09 2018 GLOBE NEWSWIRE -- Neon Therapeutics Inc (Nasdaq: NTGN a clinical-stage immuno-oncology company developing neoantigen-based therapeuticstoday presents updated data from NT-001 its ongoing Phase 1b clinica l trial...

More news and information about Neon Therapeutics, Inc.

Published By:

Globe Newswire: 13:00 GMT Friday 9th November 2018

Published: .

Search for other references to "neon" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us